Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

CAH requires a multidisciplinary approach, and while current treatments help, future therapies show promise.

The new anti-acne treatment HA-P5 effectively reduces acne by targeting two key receptors and avoids an enzyme that can hinder treatment.

Hair follicles can be used to study gene mutations in Stargardt disease.

Dutasteride use can lead to a stable decline in sexual function that is not affected by age or prostate size.

A 6-year-old boy's skin condition improved after stopping a specific treatment and starting new medications.

Inhibitors of 11β-HSD1 show potential for treating type 2 diabetes but require more testing for safety and effectiveness.

Most Hairless gene mutations reduce its ability to work with the Vitamin D Receptor, which might explain a certain type of hair loss.

Early diagnosis and genetic counseling are crucial for managing adrenoleukodystrophy.

Mutations in three genes cause Uncombable Hair Syndrome, leading to frizzy hair that can't be combed flat.

The protein folliculin, involved in a rare disease, works with another protein to control how cells stick together and their organization, and changes in this interaction can lead to disease symptoms.

Biotin supplements significantly improved a young girl's uncombable hair.

A new genetic mutation was found causing hair and eye issues in a boy.

The human type II 5α-reductase gene has a specific structure important for understanding certain medical conditions.

Deleting the BRD4 protein in certain skin cells causes hair loss and skin inflammation.

People with alopecia areata have higher levels of RBP4 protein and antibodies against it.

Compound 4 is a promising treatment for hair loss with low toxicity.

New findings suggest the protein linked to Birt–Hogg–Dubé syndrome is important in cell signaling and could affect treatment understanding.

A new EDA gene mutation was found in a Chinese family with a specific skin disorder.

Baricitinib and its combination with lonafarnib improve fat cell formation in certain genetic disorders.

Upadacitinib effectively treats severe alopecia areata and is safe.

AMPD is a better and less damaging alternative to ammonium hydroxide for hair bleaching.

Triple H syndrome exists and can vary in symptoms.

Mutations in specific genes cause different types of ectodermal dysplasias.

Higher RBP4 levels are linked to severe alopecia areata, but genetic variant rs3758539 doesn't affect baricitinib response.

Combining UVB irradiation and anti-CD154 antibody improves hair follicle transplant survival.

Hoyeraal-Hreidarsson syndrome in infants causes severe gastrointestinal issues.

Different enzymes are active in different parts of developing mouse organs.

Severe genetic variants in children with a specific adrenal condition match predicted symptoms well, but milder variants do not.

AKR1D1 controls glucocorticoid levels and receptor activity in liver cells.

Upadacitinib effectively improved severe atopic dermatitis and alopecia universalis in a 29-year-old man.